STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells (Q91211189)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158673%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

title

STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158673%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

author name string

Prajna Guha

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158673%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Jillian Gardell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158673%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Josephine Darpolor

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158673%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Marissa Cunetta

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158673%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Matthew Lima

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158673%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

George Miller

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158673%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

N Joseph Espat

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158673%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Richard P Junghans

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158673%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Steven C Katz

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158673%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

publication date

29 August 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158673%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158673%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158673%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158673%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

page(s)

533-548

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158673%20AND%20SRC:MED&resulttype=core&format=json

Immunosuppression in liver tumors: opening the portal to effective immunotherapy.

20 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Conventional liver CD4 T cells are functionally distinct and suppressed by environmental factors

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Tumor MHC class I expression improves the prognostic value of T-cell density in resected colorectal liver metastases.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Activated cytotoxic lymphocytes promote tumor progression by increasing the ability of 3LL tumor cells to mediate MDSC chemoattraction via Fas signaling.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Stat proteins and oncogenesis

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Myeloid-derived suppressor cells as regulators of the immune system

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

The STATs of cancer--new molecular targets come of age

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Fas/FasL interaction: a novel immune therapy approach with immobilized biologicals

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Fas signal promotes lung cancer growth by recruiting myeloid-derived suppressor cells via cancer cell-derived PGE2.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

PGE(2)-driven induction and maintenance of cancer-associated myeloid-derived suppressor cells

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Role of apoptosis resistance in immune evasion and metastasis of colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Bax suppresses tumorigenesis and stimulates apoptosis in vivo

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Suppression of cancer relapse and metastasis by inhibiting cancer stemness

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Stattic: a small-molecule inhibitor of STAT3 activation and dimerization

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Transcriptional regulation of myeloid-derived suppressor cells

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Frontline Science: Functionally impaired geriatric CAR-T cells rescued by increased α5β1 integrin expression.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

GM-CSF in inflammation and autoimmunity.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

The phosphatidylinositol 3-kinase/Akt and c-Jun N-terminal kinase signaling in cancer: Alliance or contradiction? (Review).

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Distinct populations of metastases-enabling myeloid cells expand in the liver of mice harboring invasive and preinvasive intra-abdominal tumor

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Suppression of prostate cancer progression by cancer cell stemness inhibitor napabucasin

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Targeting STAT3 in adoptively transferred T cells promotes their in vivo expansion and antitumor effects.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Loss of STAT3 in murine NK cells enhances NK cell-dependent tumor surveillance

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Regulating the suppressors: apoptosis and inflammation govern the survival of tumor-induced myeloid-derived suppressor cells (MDSC).

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Apoptosis: a review of programmed cell death

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Bcl-2 and the ICE family of apoptotic regulators: making a connection.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Mitochondrial control of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Fas- or ceramide-induced apoptosis is mediated by a Rac1-regulated activation of Jun N-terminal kinase/p38 kinases and GADD153

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Fas induces cytoplasmic apoptotic responses and activation of the MKK7-JNK/SAPK and MKK6-p38 pathways independent of CPP32-like proteases.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

p38 mitogen-activated protein kinase is involved in Fas ligand expression.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

p38 protects human melanoma cells from UV-induced apoptosis through down-regulation of NF-kappaB activity and Fas expression

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

JNK activation is not required for Fas-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

The Bax N terminus is required for negative regulation by the mitogen-activated protein kinase kinase and Akt signaling pathways in T cells

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Signal transducer and activator of transcription 5 (STAT5), a crucial regulator of immune and cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Sensitization of osteosarcoma cells to apoptosis by oncostatin M depends on STAT5 and p53.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

NF-κB and STAT3 - key players in liver inflammation and cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Shaping gene expression in activated and resting primary macrophages by IL-10.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

IL-23 promotes tumour incidence and growth

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

The role of interleukin-2 during homeostasis and activation of the immune system

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Rational combination of MEK inhibitor and the STAT3 pathway modulator for the therapy in K-Ras mutated pancreatic and colon cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

Carcinoembryonic antigen-immunoglobulin Fc fusion protein (CEA-Fc) for identification and activation of anti-CEA immunoglobulin-T-cell receptor-modified T cells, representative of a new class of Ig fusion proteins

1 reference

https://api.crossref.org/works/10.1038%2FS41388-018-0449-Z

7 January 2021

10.1038/S41388-018-0449-Z

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158673%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

1 reference